These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 21508749)

  • 1. Continuation and satisfaction of reversible contraception.
    Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
    Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year continuation of reversible contraception.
    Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
    Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.
    Brunie A; Stankevitz K; Nwala AA; Nqumayo M; Chen M; Danna K; Afolabi K; Rademacher KH
    Lancet Glob Health; 2021 Oct; 9(10):e1431-e1441. PubMed ID: 34474001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of long-acting reversible contraception.
    Winner B; Peipert JF; Zhao Q; Buckel C; Madden T; Allsworth JE; Secura GM
    N Engl J Med; 2012 May; 366(21):1998-2007. PubMed ID: 22621627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
    Diedrich JT; Klein DA; Peipert JF
    Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Paul R; Huysman BC; Maddipati R; Madden T
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
    Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
    Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Krashin J; Tang JH; Mody S; Lopez LM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
    Allsworth JE; Secura GM; Ajibade OO; Peipert JF
    J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil.
    Laporte M; Marcelino AC; da Cunha Pereira P; Espejo-Arce X; Juliato CT; Bahamondes L
    Int J Gynaecol Obstet; 2024 Jul; 166(1):305-311. PubMed ID: 38328989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's satisfaction with and ongoing use of hormonal long-acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd).
    Black KI; McGeechan K; Watson CJ; Lucke J; Taft A; McNamee K; Haas M; Peipert JF; Mazza D
    Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):448-453. PubMed ID: 33599984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.